$1M Funding Boost for Flagship Emerging Leader Award
Mar 25, 2026
View online
The Mark Foundation for Cancer Research Announces Global Expansion and $1M Funding Boost for Flagship Emerging Leader Award
Osimertinib Plus Chemotherapy Improves Outcomes in EGFR/TP53 mutant NSCLC: The TOP Study
Belén Garijo: Merck Ranked No. 2 in the Global Pharma AI Readiness Index
Japan Approves Risovalisib For PIK3CA-Mutated Ovarian Clear Cell Carcinoma
Multiple Myeloma Awareness Month 2026: What Robert Orlowski’s Daily Research Highlights Tell Us
The 12 New Drugs on the Horizon Presentation Titles for the AACR Annual Meeting 2026
European Cancer Mission Fair in Nicosia, Cyprus 2026
OCRA Collaborative Research Development Grant – Microsoft AI for Good Lab (2027)
CPRIT Individual Investigator Research Awards for Computational and Systems Biology of Cancer (IIRACSBC) (FY2027)
CPRIT Individual Investigator Research Awards for Cancer in Children and Adolescents (IIRACCA) (FY2027)
CPRIT Individual Investigator Research Awards for Clinical Trials (IIRACT) (FY2027)
NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care
2026 Japanese Society of Medical Oncology Annual Meeting
NCCN 2026 Nursing Program: Advancing Oncology Nursing
Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
